# Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers

> **NCT00368160** · PHASE1 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** Eszopiclone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00368160
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368160, "Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00368160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*